⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Stella Mental Health Expands Boston-Area Services with New Newton Clinic as Chief Psychiatric Officer Dr. Brian Boyle Selected as 2026 National SPRAVATO® Bureau Speaker
prnewswire.com
JNJ
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
globenewswire.com
SUPN
MGTX
JNJ
ARWR
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
prnewswire.com
JNJ
CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
prnewswire.com
BMY
GILD
JNJ
CRSP
ALLO
CART
Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer
prnewswire.com
JNJ
PFE
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
prnewswire.com
JNJ
MEXC and Ondo Finance Expand Tokenized Stock Partnership with 17 New Spot Pairs and Zero-Fee Trading
globenewswire.com
MSFT
JNJ
JPM
BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight
prnewswire.com
ABBV
AMGN
AZN
BMY
GILD
JNJ
LLY
MRK
NVS
PFE
SNY
TMO
3 Day Pharma Mini MBA Training Course: Translate Your Learning Into New Behaviours and Improvements (ONLINE EVENT: Mar 18th - Mar 20th, 2026)
globenewswire.com
PFE
MRK
JNJ
GSK
Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms
accessnewswire.com
ABBV
BMY
JNJ
LLY
NVS
REGN
BIIB